New spatial imaging system advances tissue proteomics research

Thermo Fisher Scientific has launched the Invitrogen™ EVOS™ S1000 Spatial Imaging System, designed to help researchers generate high-quality multiplexed images while streamlining sample processing.

The EVOS S1000 overcomes key challenges in fluorescent microscopy by enabling researchers to capture high-resolution images of multiple tissue samples in just hours. Its advanced spectral technology allows simultaneous imaging of up to nine different protein targets, minimising the need for multiple imaging rounds and preserving tissue integrity.

"Understanding tissue structure is essential for advancing treatments for solid tumours and neurodegenerative diseases," said Trisha Dowling, Vice President and General Manager for flow and imaging technologies at Thermo Fisher Scientific. "The EVOS S1000 provides a detailed view of tissue microenvironments in their native state, helping researchers accelerate their studies and maximise insights from their samples."

 The system’s compatibility with a wide range of reagents and antibodies ensures seamless integration into existing workflows.

"Our lab manages everything from project design to imaging, so delivering high-quality results efficiently is crucial," said Carolina Oses Sepúlveda, Researcher and Lab Manager for Spatial Proteomics at SciLifeLab Stockholm. "The EVOS S1000 gives us the flexibility to use any antibody or reagent - or even work without antibodies - reducing processing time and expanding our research capabilities."

Now available in the United States and Europe, the EVOS S1000 Spatial Imaging System provides researchers with powerful tools to explore complex biological systems and advance disease research.

 More information online